5PSQ-067 Are poly (ADP-ribose) polymerase inhibitors well tolerated by our patients? A safety study in real-word practice
| Autor: | D Rubio Calvo, E Tejedor Tejada, E Martinez Velasco, J Urda, MA Castro Vida |
|---|---|
| Rok vydání: | 2022 |
| Zdroj: | Section 5: Patient safety and quality assurance. |
| DOI: | 10.1136/ejhpharm-2022-eahp.295 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|